Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-25 @ 12:39 AM
Ignite Modification Date:
2025-12-25 @ 12:39 AM
NCT ID:
NCT02739867
Eligibility Criteria:
Inclusion Criteria:
* First episode of objectively confirmed, symptomatic, unprovoked symptomatic pulmonary embolism and/or distal or proximal deep vein thrombosis of the leg
* Age 40 years or older
* Written informed consent
Exclusion Criteria:
* known malignant disease prior to VTE defined as a cancer diagnosis or cancer treatment within the past 5 years (of note: suspected but unconfirmed cancer at diagnosis of VTE is allowed);
* trauma or fracture of the leg, surgical procedures, general anesthesia, or immobilization greater than 3 days within previous 3 months;
* previous unprovoked venous thromboembolism;
* known hereditary or acquired thrombophilia;
* current pregnancy or puerperium (up to 3 months postpartum);
* current estrogen therapy.
* Greater than 10 days after VTE diagnosis;
* Inability for blood withdrawal at baseline;
* Inability or refusal to provide written informed consent.
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
40 Years
Study:
NCT02739867
Study Brief:
Protocol Section:
NCT02739867